Researchers from Turku Bioscience Center at the University of Turku, Finland, have developed a new computational method to ...
The bidirectional flyback-based active cell balancing approach offers a compact and scalable solution for modern multicell ...
CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company’s investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback